Equity Details
Price & Market Data
Price: $6.70
Daily Change: +$0.19 / 2.84%
Daily Range: $6.34 - $6.80
Market Cap: $651,454,784
Daily Volume: 563,862
Performance Metrics
1 Week: 8.24%
1 Month: 8.06%
3 Months: 15.72%
6 Months: 68.34%
1 Year: 48.23%
YTD: 34.27%
About Anteris Technologies Global Corp. (AVR)
A complete picture of Anteris Technologies Global Corp. (AVR). Price: 6.70, daily change: +$0.19 / 2.84%. Market cap: 651,454,784. All key performance data is updated.
Company Details
Employees: 174
Sector: Health technology
Industry: Medical specialties
Country: United States
Details
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.